(PRESS RELEASE) ALEXANDRIA, VA — MellingMedical announced a new distribution agreement with Optos Inc, a world leader in the design and manufacture of the only clinically proven ultra-widefield retinal imaging technology, to deliver its state-of-the-art equipment to facilities across the federal health care system.
“As they work to accommodate growing caseloads, doctors in the federal health system are looking for tools that work quickly and accurately, so the addition of Optos technology to our portfolio is timed just right,” said Chris Melling, founder and CEO of MellingMedical. “When it comes to so many of the threats to vision, early detection of issues is critical, and Optos is the right tool for that job.”
Optos introduced ultra-widefield (UWF) retinal imaging to enable eyecare professionals to discover, diagnose, document and treat ocular pathology that may first present in the periphery, thus escaping detection by traditional examination equipment. Their UWF, high-resolution retinal imaging devices are the only products that meet the definition of “ultra-widefield” as an image that shows retina beyond the vortex vein ampullae in all 4 quadrants in a single capture.
“Optos was founded 29 years ago with the goal to make a patient-friendly device to capture a digital ultra-widefield image of the retina. Our objective was to harness technology to help our customers save sight and save lives,” said Optos CEO, Rob Kennedy. “MellingMedical is uniquely positioned to offer our technology to vision specialists in the federal health care system, to support them to diagnose and treat problems that might otherwise have gone undetected.”
For more information on MellingMedical’s full line of medical/surgical supplies, durable medical equipment and pharmaceutical products, visit MellingMedical.com.
View Comments